企業プロフィール
Summit Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- SMMT
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United Kingdom with U
株価パフォーマンス
12.78 USD (-4.27%)
終値
最終更新: 2026年8月17日
11.5B USD
時価総額
株価変動の要因
As of Aug 17, 2026, SMMT closed down 4.27% at $12.78. No new same-company headline was identified in the current news window.
企業概要
事業概要
Summit Therapeutics is a biopharmaceutical company centered on oncology and the commercial potential of its lead cancer programs. The company has become a market focus because of its high-profile clinical and strategic story.
所在地とセクター分類
Headquartered in the United Kingdom with U.S. market exposure and listed on NASDAQ, Summit sits in oncology biotechnology.
ビジネスモデルの特徴
Its model is driven by clinical data, partnering, and the possibility of turning a focused oncology program into a major value driver.
バイオ業界での位置付け
Summit is a high-beta oncology name where data and strategic developments can quickly dominate the valuation.
今後のカタリスト
- Summit Therapeutics's catalysts are ivonescimab development and the next oncology readouts that could keep the PD-1 / VEGF story moving. The company matters most when the clinical data stay ahead of the hype.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。